Integrated Biopharma INBP
OTC INBP
$0.18 +0.02 (+12.50%)
At close: Oct 1, 2026 · 4:00 PM EDT

Integrated Biopharma (INBP) Cash & Equivalents (2010 - 2026)

Updated

Integrated Biopharma's Cash & Equivalents was $4.47 million in fiscal Q4 2026 (quarter ended Jun 30, 2026), up 23.7% from $3.62 million a year earlier but down 23.3% from the prior quarter.

Analysis

Integrated Biopharma (INBP) Cash & Equivalents (2010 - 2026) Analysis & Trends

From fiscal Q1 2011 onward, Integrated Biopharma has reported Cash & Equivalents for 62 quarters.

  • Cash & Equivalents has now increased for five consecutive fiscal years, with a five-year compound annual growth rate of 84.3% (FY2021 to FY2026).
  • In earlier fiscal years, Cash & Equivalents was $3.62 million in FY2025 (+115.6%), $1.68 million in FY2024 (+27.4%), $1.32 million in FY2023 (+297.6%) and $331,000 in FY2022 (+57.6%).
  • Quarterly Cash & Equivalents has moved between $57,000 (fiscal Q1 2022) and $5.83 million (fiscal Q3 2026) over five years.
  • Compared with a year earlier, Cash & Equivalents has increased for seven straight quarters, with growth averaging 91.3% over the last eight quarters.
  • The best year-over-year quarter for Cash & Equivalents over five years was fiscal Q3 2023 (growth of 858.0%); the worst was fiscal Q1 2022 (a decline of 84.6%).
  • Per Business Quant data, INBP's Cash & Equivalents in the three fiscal quarters before Q4 2026 was $5.83 million (Q3 2026), $5.31 million (Q2 2026) and $4.73 million (Q1 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Procter & Gamble 336.76 Bn 292.75 Bn 10.28 Bn 9.94 Bn
2 Colgate Palmolive 67.18 Bn 62.24 Bn 3.30 Bn 1.37 Bn
3 Estee Lauder Companies 33.32 Bn 21.40 Bn 2.74 Bn 3.50 Bn
4 Kenvue 33.09 Bn 28.70 Bn 2.30 Bn 1.11 Bn
5 Kimberly Clark 31.38 Bn 28.71 Bn 1.60 Bn 956.00 Mn
6 Church & Dwight 22.37 Bn 20.90 Bn 693.90 Mn 254.80 Mn
7 Clorox 9.72 Bn 8.16 Bn 804.00 Mn 143.00 Mn
8 e.l.f. Beauty 6.17 Bn 5.15 Bn 398.84 Mn 344.24 Mn
9 Reynolds Consumer Products 4.71 Bn 4.37 Bn 245.00 Mn 66.00 Mn
10 Integrated Biopharma 5.59 Mn -14.75 Mn 28,000.00 4.47 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.47 Mn
Mar 31, 2026 5.83 Mn
Dec 31, 2025 5.31 Mn
Sep 30, 2025 4.73 Mn
Jun 30, 2025 3.62 Mn
Mar 31, 2025 2.96 Mn
Dec 31, 2024 2.46 Mn
Sep 30, 2024 2.27 Mn
Jun 30, 2024 1.68 Mn
Mar 31, 2024 2.02 Mn
Dec 31, 2023 732,000.00
Sep 30, 2023 2.59 Mn
Jun 30, 2023 1.32 Mn
Mar 31, 2023 2.53 Mn
Dec 31, 2022 1.09 Mn
Sep 30, 2022 1.17 Mn
Jun 30, 2022 331,000.00
Mar 31, 2022 264,000.00
Dec 31, 2021 162,000.00
Sep 30, 2021 57,000.00
API Access

Integrated Biopharma Cash & Equivalents API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=INBP&period=max&api_key=YOUR_API_KEY